A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A study to determine the ability of different doses of PF-610,355 to open the airways in
asthmatic patients by comparison with placebo and a marketed drug that also opens the airways
in asthmatic patients.